Slide 1: Important information
Important information This presentation includes forward-looking statements including, but not limited to, statements relating to operational and financial performance, market conditions, and other similar matters. These forward-looking statements are based on current expectations about future event
Slide 2: Thought Leader in Precision Radiation Medicine
Thought Leader in Precision Radiation Medicine Dr. Richard Hausmann President and CEO
Slide 3: Before we start
| Before we start |
Slide 4: Radiation medicine proven to make a great difference in oligometastatic disease
Radiation medicine proven to make a great difference in oligometastatic disease 3 newly published trials report survival benefit of consolidative radiation therapy Lung cancer: Gomez et al ASTRO 2018 Prostate cancer: Parker et al ESMO 2018 All tumors: Palma et al ASTRO 2018
Slide 5: A quick recap from the Capital Markets Day
A quick recap from the Capital Markets Day
Slide 6: Message 1: Elekta is a better company now
Message 1: Elekta is a better company now
Slide 7: I see opportunity to improve Elekta even further
I see opportunity to improve Elekta even further
Slide 8: Message 2: Our market is there and strong
Message 2: Our market is there and strong
Slide 9: An attractive growing global market
An attractive growing global market Demographics Growing cancer incidence $ ~7bn ~7% Global radiotherapy Current market market growth rate Breakthrough technologies and Growing need digitalization for cost- efficient in health care cancer care
Slide 10: Message 3: We have a clear strategy forward
Message 3: We have a clear strategy forward
Slide 11: We focus on Precision Radiation Medicine
We focus on... Precision Radiation Medicine
Slide 12: Our history is what drives us forward
Our history is what drives us forward Elekta was founded by Lars Leksell more than 46 years ago. We have dedicated ourselves to pioneering precision radiation medicine. Dr. Lars Leksell (1907 – 1986) Professor of Neurosurgery
Slide 13: Focus where it matters
SOFTWARE MOSAIQ MOSAIQ METRIQ/LGK Oncology Oncology SOLUTIONS Information System Analytics Cancer Registries Oncology Informatics Monaco Adaptive Image & Plan Plan of care planning Review SERVICE & SUPPORT Treatment pathway Management New version TREATMENT SOLUTIONS Versa HD Unity Flexitron Icon 13
Slide 14: Elekta Unity is precision radiation medicine by definition
Elekta Unity is precision radiation medicine by definition Elekta Unity has a CE Mark but is not available for commercial distribution or sale in the U.S.
Slide 15: Patients are being treated as we speak
Patients are being treated as we speak Courtesy UMC, Utrecht Metastatic pelvic lymph node Metastatic axilla lymph node T2w, TE 140ms, 3.5 mm sl., 1.1 x 1.1 mm res. 3D T2w STIR, 1.5 mm sl., 1.5 x 1.5 mm res. Elekta Unity has a CE Mark but is not available for commercial distribution or sale in the U.
Slide 16: At multiple locations
At multiple locations Courtesy University of Tubingen Treatment plan for 35 Gy in 5 fractions (Left) Live MRI - 5 frames/s (right) Treatment of metastatic pelvic lymph node Pre-irradiated area (bowel, bone) with the need for maximum precision T2w, TE 140ms, 3.5 mm sl., 1.1 x 1.1 mm res. Elekta Unity
Slide 17: Our pioneers
Our pioneers Elekta Unity has a CE Mark but is not available for commercial distribution or sale in the U.S.
Slide 18: Driving precision radiation medicine across our portfolio
Driving precision radiation medicine across our portfolio
Slide 19: Driving portfolio growth
Driving portfolio growth 14% Linacs Informatics • Unity and “halo effect” • Drive software penetration • Introduce HD Edition through bundling 8% • Capture upgrade cycles • New functionality and add-ons 65% 13% Neurosurgery Brachytherapy • Capture SRS growth with LGK • Re-establish specialist sales
Slide 20: Introducing our new family of HD Linacs here at ASTRO
Introducing our new family of HD Linacs here at ASTRO Versa HD Infinity HD Synergy HD Push the boundaries of your Flexibility redefined, truly Proven technology for everyone, stereotactic capabilities multifunctional everywhere
Slide 21: Elekta Digital – guiding tomorrow's solutions
Elekta Digital – guiding tomorrow’s solutions Super accurate AI based contouring will enhance confidence Complete virtual assistant joining patients and family support systems from home to hospital and beyond Genetic profiling means we already know how we will treat the patient… even before they are
Slide 22: MOSAIQ Plaza – a strong foundation to expand our future offering
MOSAIQ Plaza – a strong foundation to expand our future offering Customer workflow apps (Genesis care) … IBM Watson Whiteboard China workflow Workspace management Palabra Patient voice engagement automation Resource management (MOA)
Slide 23: Precision radiation medicine made easy to use and more accessible
Precision radiation medicine made easy to use and more accessible • Turnkey solutions • Ease of installation • Intelligent automation • Affordability • Supported by solid training & education
Slide 24: We have set ambitious targets
We have set ambitious targets FY18/19 Guidance Mid Term Scenario* Until FY22/23 8-10% Net Sales ~7% Net Sales CAGR over period (based on constant exchange rates) EBITA >20% EBITA ~20% with expansion of up to 200 BPS in the end of the period * Replaces Elekta’s current long-term financial ambitions
Slide 25: My Promise
My Promise: Drive Elekta into the future as we drove it the last two years!
Slide 26: We will be #1
We will be #1
Slide 27: CJElekta
CJElekta